$DSCO Company News Tesla rebounds as Musk weighs
Post# of 145233

Tesla rebounds as Musk weighs in on Model S fire 3:34 p.m. Oct. 4, 2013 - Sue Chang
In focus: Bulls trying to retain control 6:34 p.m. Aug. 29, 2012 - Lawrence G. McMillan
Friday’s biggest gaining and declining stocks 3:24 p.m. March 16, 2012 - Kate Gibson
Discovery Labs prices shares at 20% discount 11:16 a.m. March 16, 2012 - MarketWatch.com
Wednesday’s biggest gaining and declining stocks 5:02 p.m. March 7, 2012 - Sue Chang
Discovery Labs pares gains, investors digest costs 12:32 p.m. March 7, 2012 - MarketWatch.com
Stocks to watch Wednesday: Priceline, Cypress 6:37 a.m. March 7, 2012 - MarketWatch
Pandora down, Discovery Labs up after hours 7:15 p.m. March 6, 2012 - Carla Mozee
Discovery Labs rockets on FDA approval 5:55 p.m. March 6, 2012 - Val Brickates Kennedy
Top longs and shorts to watch 12:18 p.m. March 6, 2012 - The Trading Deck
How to play the January Effect 12:01 a.m. Jan. 4, 2012 - Mark Hulbert
Discovery Labs responds to FDA on Surfaxin 7:04 a.m. Sept. 6, 2011 - MarketWatch.com
Drug stocks slide; Orexigen shines 2:48 p.m. June 1, 2011 - Val Brickates Kennedy
Discovery Labs jumps 16% on drug analysis 9:14 a.m. June 1, 2011 - Val Brickates Kennedy
Genzyme, Sanofi grab drug-sector spotlight 2:04 p.m. Feb. 16, 2011 - Val Brickates Kennedy
Discovery shares implode on stock offer pricing 12:10 p.m. Feb. 16, 2011 - Val Brickates Kennedy
7 Biotechnology Stocks to Sell Now 4:00 a.m. Today - InvestorPlace.com
7 Biotechnology Stocks to Sell Now 5:15 a.m. Dec. 4, 2013 - InvestorPlace.com
8 Biotechnology Stocks to Sell Now 7:45 a.m. Nov. 27, 2013 - InvestorPlace.com
8 Biotechnology Stocks to Sell Now 7:45 a.m. Nov. 20, 2013 - InvestorPlace.com
Discovery Laboratories Management Discusses Q3 2013 Results - Earnings Call Transcript 2:01 p.m. Nov. 13, 2013 - Seeking Alpha
7 Biotechnology Stocks to Sell Now 4:00 a.m. Nov. 13, 2013 - InvestorPlace.com
10-Q: DISCOVERY LABORATORIES INC /DE/ 4:20 p.m. Nov. 12, 2013 - Edgar Online - (EDG = 10Q, 10K)
Discovery Laboratories: Removal Of Financing Overhang A Catalyst For The Stock 2:46 p.m. Nov. 12, 2013 - Seeking Alpha
Amazon’s Sunday Service, PepsiCo Focuses on India, and 3 More Hot Stocks 2:44 p.m. Nov. 11, 2013 - Wall St. Cheat Sheet
UPDATE: Piper Jaffray Initiates Coverage on Discovery Laboratories on Emerging Respiratory Franchise at Breathtaking Value 8:15 a.m. Nov. 11, 2013 - benzinga.com
Benzinga's Top Initiations 6:58 a.m. Nov. 11, 2013 - benzinga.com
9 Biotechnology Stocks to Sell Now 5:15 a.m. Nov. 6, 2013 - InvestorPlace.com
First Week Of DSCO December 21st Options Trading 10:34 a.m. Nov. 1, 2013 - TheStreet.com
7 Biotechnology Stocks to Sell Now 5:30 a.m. Oct. 30, 2013 - InvestorPlace.com
7 Biotechnology Stocks to Sell Now 5:30 a.m. Oct. 23, 2013 - InvestorPlace.com
Update on Discovery Labs' RDS Drugs - Analyst Blog 12:50 p.m. Oct. 21, 2013 - Zacks.com
Discovery Labs Reports IND Submission for AEROSURF, Sees Neonatal Program Starting Q4 6:46 a.m. Oct. 17, 2013 - benzinga.com
8 Biotechnology Stocks to Sell Now 7:00 a.m. Oct. 16, 2013 - InvestorPlace.com
4 Biotechnology Stocks With Room To Climb 9:10 a.m. Oct. 15, 2013 - Seeking Alpha
7 Biotechnology Stocks to Sell Now 4:15 a.m. Oct. 9, 2013 - InvestorPlace.com
Discovery Labs to Present at the 25th Annual Piper Jaffray Health Care Conference 7:45 a.m. Nov. 21, 2013 - PR Newswire
Morning Research: Inovio Pharma Inc., Sequenom Inc., Nektar Therapeutics, and Discovery Laboratories Inc. 9:03 a.m. Nov. 19, 2013 - PR Newswire
Discovery Labs Reports Third Quarter 2013 Financial Results 4:50 p.m. Nov. 12, 2013 - PR Newswire
Discovery Labs Receives FDA Clearance of IND to Initiate AEROSURF® Phase 2 Clinical Program 4:05 p.m. Nov. 12, 2013 - PR Newswire
ZLCS, CLRX, DSCO and GALE added to NASDAQ Active Stock Watch List at GSR 10:20 a.m. Nov. 11, 2013 - ACCESSWIRE
Discovery Labs to Host Conference Call to Discuss Third Quarter 2013 Results on Wednesday, November 13, 2013 8:30 a.m. Nov. 8, 2013 - PR Newswire
Discovery Labs Announces U.S. Commercial Launch of SURFAXIN® (lucinactant) 8:00 a.m. Nov. 8, 2013 - PR Newswire
Discovery Labs Announces Completion of $50 Million Public Offering 4:05 p.m. Nov. 5, 2013 - PR Newswire
Discovery Labs Prices $50 Million Public Offering of Common Stock 7:30 a.m. Oct. 31, 2013 - PR Newswire
Discovery Labs Announces Proposed Public Offering of Common Stock 3:01 p.m. Oct. 30, 2013 - PR Newswire
Today's Research: Inovio Pharmaceuticals Inc., Sequenom Inc., Nektar Therapeutics, and Discovery Laboratories Inc. 8:00 a.m. Oct. 28, 2013 - PR Newswire
Discovery Labs Announces IND Submission for AEROSURF® 6:45 a.m. Oct. 17, 2013 - PR Newswire
Product Development Strategies, FDA Approval, Incremental Agreement, New Clinical Studies, and Other Announcements - Research Report on Amarin, Discovery Labs, Auxilium, Novavax, and Accuray 7:00 a.m. Oct. 9, 2013 - PR Newswire
Discovery Labs Announces Notice of Allowance for a U.S. Patent Supporting the AEROSURF® Development Program 6:45 a.m. Oct. 8, 2013 - PR Newswire
Discovery Labs Announces FDA Approval of SURFAXIN® (lucinactant) Updated Product Specifications 6:45 a.m. Oct. 4, 2013 - PR Newswire
Wall Street Fundamentals Releases New In-Depth Stock Reports on ACHN, BLRX, DSCO and ONCY 7:51 a.m. Sept. 10, 2013 - ACCESSWIRE
Discovery Labs to Present at Stifel Healthcare Conference 2013 7:00 a.m. Sept. 5, 2013 - PR Newswire
Discovery Labs Reports Second Quarter 2013 Financial Results 6:45 a.m. Aug. 8, 2013 - PR Newswire
Discovery Labs to Report Second Quarter 2013 Results and Hold Conference Call on Thursday, August 8, 2013 7:19 a.m. July 25, 2013 - PR Newswire
Discovery Labs Presents Final Assessment in a Series of Pharmacoeconomic Analyses that Explore Impact of Reintubation on Healthcare Costs 6:45 a.m. June 11, 2013 - PR Newswire

